Clinical Trial Update: PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor (Lung, Liver and Stomach) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study of a PD-1 antibody expressing CAR-T cell therapy targeting EGFR family member positive advanced solid tumor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Hepatocellular Carcinoma
• Lung Cancer

Drugs mentioned

• PD-1 antibody expressing CAR-T cells

Snippet

Sponsor: Shanghai International Medical Center | Conditions: PD-1 Antibody, CAR-T Cells | Phase 1, Phase 2 | Status: UNKNOWN